Get In Touch
We are a pre-clinical stage pharmaceutical company using our proprietary NCE to treat acute and chronic inflammation. We will offer our products for licensing post Ph II studies in high unmet need indications.
Address: 500 Cartier Blvd W
Canada H7V 5B7
Phone: 514 883 3447
Enhanced Ocular Delivery of TA-A001
Tetra Bio-Pharma and Altus Formulation Form New Company “TALLC” to Exploit TA-A001
© TALLC Inc. 2020